Cargando…

Development of a Machine Learning-Based Prognostic Model for Hormone Receptor-Positive Breast Cancer Using Nine-Gene Expression Signature

BACKGROUND: Determining the prognosis of hormone receptor positive (HR(+)) breast cancer (BC), which accounts for 80% of all BCs, is critical in improving survival outcomes. Stratifying individuals at high risk of BC-related mortality and improving prognosis has been the focus of research for over a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takeshita, Takashi, Iwase, Hirotaka, Wu, Rongrong, Ziazadeh, Danya, Yan, Li, Takabe, Kazuaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588506/ https://www.ncbi.nlm.nih.gov/pubmed/37869243 http://dx.doi.org/10.14740/wjon1700

Ejemplares similares

GALNT1 Expression Is Associated with Angiogenesis and Is a Prognostic Biomarker for Breast Cancer in Adolescents and Young Adults (AYA)
por: Oshi, Masanori, et al.
Publicado: (2023)

Machine Learning Identifies a Signature of Nine Exosomal RNAs That Predicts Hepatocellular Carcinoma
por: Yap, Josephine Yu Yan, et al.
Publicado: (2023)

Lysophosphatidic Acid Receptor Signaling in the Human Breast Cancer Tumor Microenvironment Elicits Receptor-Dependent Effects on Tumor Progression
por: Benesch, Matthew G. K., et al.
Publicado: (2023)

Clinical significance of monitoring ESR1 mutations in circulating cell-free DNA in estrogen receptor positive breast cancer patients
por: Takeshita, Takashi, et al.
Publicado: (2016)

A nine-hub-gene signature of metabolic syndrome identified using machine learning algorithms and integrated bioinformatics
por: Liu, Guanzhi, et al.
Publicado: (2021)

Should we target “intermediate expression” of HER2 in older estrogen receptor positive patients?
por: Tokumaru, Yoshihisa, et al.
Publicado: (2020)

G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer
por: Oshi, Masanori, et al.
Publicado: (2020)

Identification of a prognostic signature of nine metabolism-related genes for hepatocellular carcinoma
por: Tang, Chaozhi, et al.
Publicado: (2020)

Late recurrence of breast cancer is associated with pro-cancerous immune microenvironment in the primary tumor
por: Takeshita, Takashi, et al.
Publicado: (2019)

Fibroblast growth factor receptor‐1 protein expression is associated with prognosis in estrogen receptor‐positive/human epidermal growth factor receptor‐2‐negative primary breast cancer
por: Tomiguchi, Mai, et al.
Publicado: (2016)

A robust prognostic signature for hormone-positive node-negative breast cancer
por: Griffith, Obi L, et al.
Publicado: (2013)

Outcome of Everolimus-Based Therapy in Hormone-Receptor-Positive Metastatic Breast Cancer Patients After Progression on Palbociclib
por: Dhakal, Ajay, et al.
Publicado: (2020)

Development of a prognostic signature for esophageal cancer based on nine immune related genes
por: Zhang, Zhi, et al.
Publicado: (2021)

An immune-relevant signature of nine genes as a prognostic biomarker in patients with gastric carcinoma
por: Wang, Bing, et al.
Publicado: (2020)

A new immune checkpoint-associated nine-gene signature for prognostic prediction of glioblastoma
por: Jin, Xiao, et al.
Publicado: (2023)

Clinical Relevance of Estrogen Reactivity in the Breast Cancer Microenvironment
por: Takeshita, Takashi, et al.
Publicado: (2022)

Genetic and environmental factors and serum hormones, and risk of estrogen receptor-positive breast cancer in pre- and postmenopausal Japanese women
por: Guo, Jiazhi, et al.
Publicado: (2017)

Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer
por: Gong, Chang, et al.
Publicado: (2016)

An Integrative Analysis of PIK3CA Mutation, PTEN, and INPP4B Expression in Terms of Trastuzumab Efficacy in HER2-Positive Breast Cancer
por: Sueta, Aiko, et al.
Publicado: (2014)

Prognostic role of PIK3CA mutations of cell‐free DNA in early‐stage triple negative breast cancer
por: Takeshita, Takashi, et al.
Publicado: (2015)

Identification of a nine-gene prognostic signature for gastric carcinoma using integrated bioinformatics analyses
por: Wu, Kun-Zhe, et al.
Publicado: (2020)

PTIP Associated protein 1, PA1, Is an Independent Prognostic Factor for Lymphnode Negative Breast Cancer
por: Takeshita, Takashi, et al.
Publicado: (2013)

Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer
por: Yamamoto, Yutaka, et al.
Publicado: (2013)

Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer
por: Takeshita, Takashi, et al.
Publicado: (2018)

High expression of bone morphogenetic protein (BMP) 6 and BMP7 are associated with higher immune cell infiltration and better survival in estrogen receptor-positive breast cancer
por: Katsuta, Eriko, et al.
Publicado: (2019)

The Impact of Immunofunctional Phenotyping on the Malfunction of the Cancer Immunity Cycle in Breast Cancer
por: Takeshita, Takashi, et al.
Publicado: (2020)

Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer patients
por: Takeshita, Takashi, et al.
Publicado: (2017)

Ki-67 is a prognostic marker for hormone receptor positive tumors
por: Pérez-López, M. E., et al.
Publicado: (2016)

Identification of a novel nine‐SnoRNA signature with potential prognostic and therapeutic value in ovarian cancer
por: Zhu, Wenjing, et al.
Publicado: (2022)

C# machine learning projects: nine real-world projects to build robust and high-performing machine learning models with C#
por: Hwang, Yoon Hyup
Publicado: (2018)

Decreased Lipid Phosphate Phosphatase 1/3 and Increased Lipid Phosphate Phosphatase 2 Expression in the Human Breast Cancer Tumor Microenvironment Promotes Tumor Progression and Immune System Evasion
por: Benesch, Matthew G. K., et al.
Publicado: (2023)

A Comparison of Nine Machine Learning Mutagenicity Models and Their Application for Predicting Pyrrolizidine Alkaloids
por: Helma, Christoph, et al.
Publicado: (2021)

The localization of HER4 intracellular domain and expression of its alternately-spliced isoforms have prognostic significance in ER+ HER2- breast cancer
por: Fujiwara, Saori, et al.
Publicado: (2014)

Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer
por: Wu, Mengwei, et al.
Publicado: (2019)

Construction and validation of a prognostic nine-gene signature associated with radiosensitivity in head and neck squamous cell carcinoma
por: Lu, Congxian, et al.
Publicado: (2023)

The Role of the Microbiome on the Pathogenesis and Treatment of Colorectal Cancer
por: Yu, Irene, et al.
Publicado: (2022)

CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast Cancer
por: Oshi, Masanori, et al.
Publicado: (2020)

Bioavailability Comparison of Nine Bioselenocompounds In Vitro and In Vivo
por: Takahashi, Kazuaki, et al.
Publicado: (2017)

Multigene Expression Signatures in Early Hormone Receptor Positive HER 2 Negative Breast Cancer
por: Ovcaricek, Tanja, et al.
Publicado: (2019)

MYC Targets Scores Are Associated with Cancer Aggressiveness and Poor Survival in ER-Positive Primary and Metastatic Breast Cancer
por: Schulze, Amy, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9c0hq15kt7q0g5mq4p8j5muarf